Simple Amino Acid Trick Boosts mRNA Therapy 20-Fold

Researchers find adding 3 common amino acids dramatically improves gene therapy delivery and efficacy.

Apr. 20, 2026 at 10:55am

Got story updates? Submit your updates here. ›

An abstract painting in soft, earthy tones featuring sweeping geometric shapes and precise botanical spirals, representing the complex biological processes underlying improved nanoparticle delivery for gene therapies.A conceptual illustration depicting the enhanced cellular uptake of gene therapy nanoparticles through the addition of a simple amino acid supplement.Chicago Today

A team of researchers has discovered that adding a simple mixture of three common amino acids - methionine, arginine, and serine - to lipid nanoparticles can boost mRNA delivery by up to 20-fold and raise CRISPR gene editing efficiency from 25% to nearly 90%. The breakthrough stems from studying how cells' metabolic state affects nanoparticle uptake, leading to a practical solution that could significantly improve the performance of a wide range of future mRNA and gene therapies.

Why it matters

Lipid nanoparticles are critical for delivering mRNA and gene editing therapies, but their performance has been limited by cells' ability to absorb them. This new approach provides a simple, inexpensive way to dramatically enhance nanoparticle uptake and therapeutic efficacy, potentially unlocking the full potential of these transformative technologies for treating diseases like cancer, genetic disorders, and more.

The details

The researchers found that standard lab-grown cells, which are exposed to nutrient-rich conditions, have a much higher capacity to absorb lipid nanoparticles compared to cells grown in conditions more representative of the human body. Further analysis revealed that several amino acid-related metabolic pathways were less active in the more realistic conditions, suggesting cells' limited nutrient availability constrains their ability to take up nanoparticles. By supplementing the nanoparticles with a mixture of methionine, arginine, and serine, the team was able to boost mRNA delivery 5- to 20-fold and CRISPR gene editing efficiency to 85-90% in animal studies.

  • The study was published in Science Translational Medicine on April 20, 2026.

The players

Daniel Zongjie Wang

PhD, leads the Spatiotemporal Omics Group at Biohub.

Shana O. Kelley

PhD, president of bioengineering at Biohub and head of Biohub, Chicago.

Biohub

A research institute decoding the inflammatory processes that drive a wide range of diseases.

Got photos? Submit your photos here. ›

What they’re saying

“Gene editing and mRNA-based therapies will play increasing roles in the medicine of the future, but they require LNPs to reach and enter cells. Any LNP formulation being developed today could potentially benefit from our approach.”

— Shana O. Kelley, President of bioengineering at Biohub

“The field has spent enormous effort engineering nanoparticles. We found, however, that the cell's own metabolic state is an equally important -- and addressable -- part of the equation.”

— Daniel Zongjie Wang, Leads the Spatiotemporal Omics Group at Biohub

What’s next

The researchers are planning further studies to optimize the amino acid formulation and explore its potential applications in a wider range of mRNA and gene editing therapies.

The takeaway

This simple amino acid supplement represents a practical, cost-effective way to dramatically improve the performance of lipid nanoparticle-based gene therapies, potentially unlocking new treatments for a wide range of diseases by enhancing cellular uptake and therapeutic efficacy.